Komori
Kaneko Seeds (1376) · FactIncrease in investment

Continued R&D Investment

First written in FY2016. 10 of 36 entries say "Restated". Latest entry: FY2026.

36entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2016 – FY20262016: 22017: 320172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Continued company-wide R&D activities and resource investmentA theme 202 companies write about · 0 as a headwind · 215 as a tailwind

92 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 217 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Increase in investmentAnnual report

    「Total R&D expenses for the consolidated fiscal year amounted to ¥970.086 million.」

    R&D expenses increased from ¥942.404 million in the previous fiscal year to ¥970.086 million.
  2. FY2026-H1Higher Interim R&D SpendingAnnual report

    「The Group's R&D expenses for the interim consolidated accounting period amounted to ¥463.359 million.」

    Interim R&D expenses increased from ¥447.971 million in the same period of the previous year to ¥463.359 million, and the Company continues to invest in R&D.
  3. FY2025Increase in investmentAnnual report

    「Total R&D expenses for the consolidated fiscal year amounted to ¥942.404 million.」

    R&D expenses increased from ¥917.905 million in the previous fiscal year to ¥942.404 million.
  4. FY2025-H1Increase in cumulative research and development expensesAnnual report

    「The Group's R&D expenses for the interim consolidated accounting period amounted to ¥447.971 million.」

    R&D expenses of ¥447.971 million were recorded for the interim consolidated accounting period, an increase from ¥401.079 million in the same period of the previous year.
  5. FY2024Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥917.905 million.」

    R&D expenses increased from ¥840.975 million in the previous fiscal year to ¥917.905 million.
  6. FY2024-Q3Increase in cumulative research and development expensesAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥666.333 million.」

    Research and development expenses for the cumulative third quarter were ¥666.333 million, up from ¥611.861 million in the same period of the previous year. Research and development investment continued.
  7. FY2024-Q2Increase in cumulative research and development expensesAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥440.829 million.」

    Research and development expenses for the cumulative second quarter increased from ¥373.595 million in the same period of the previous year and also from ¥401.079 million in the previous cumulative quarter.
  8. FY2024-Q1Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥220.337 million.」

    Research and development expenses for the cumulative first quarter were ¥220.337 million, up from ¥193.460 million in the same period of the previous year.
  9. FY2023Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥840.975 million.」

    Research and development expenses increased from ¥752.706 million in the previous fiscal year to ¥840.975 million.
  10. FY2023-Q3Increase in cumulative research and development expensesAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥611.861 million.」

    Research and development expenses for the cumulative third quarter were ¥611.861 million, up from ¥557.937 million in the same period of the previous year.
  11. FY2023-Q2Increase in cumulative research and development expensesAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥401.079 million.」

    Research and development expenses for the cumulative second quarter were ¥401.079 million, up from ¥373.595 million in the same period of the previous year.
  12. FY2023-Q1Quarterly R&D expenses decreasedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥193.460 million.」

    Research and development expenses were ¥193.460 million, down from ¥194.297 million in the same period of the previous year. Investment in research and development itself continued.
  13. FY2022Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥752.706 million.」

    Research and development expenses increased from ¥746.341 million in the previous fiscal year to ¥752.706 million.
  14. FY2022-Q3Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥557.937 million.」

    Research and development expenses for the cumulative third quarter were ¥557.937 million, up from ¥542.992 million in the same period of the previous year.
  15. FY2022-Q2Increase in cumulative research and development expensesAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥373.595 million.」

    Research and development expenses for the cumulative second quarter were ¥373.595 million, up from ¥361.932 million in the same period of the previous year.
  16. FY2022-Q1Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥194.297 million.」

    Research and development expenses increased from ¥183.799 million in the same period of the previous year to ¥194.297 million.
  17. FY2021Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥746.341 million.」

    Research and development expenses increased from ¥698.351 million in the previous fiscal year to ¥746.341 million.
  18. FY2021-Q3Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥542.992 million.」

    Research and development expenses increased from ¥516.791 million in the same period of the previous year to ¥542.992 million.
  19. FY2021-Q2Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥361.932 million.」

    Research and development expenses increased from ¥345.209 million in the same period of the previous year to ¥361.932 million.
  20. FY2021-Q1Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥183.799 million.」

    Research and development expenses increased from ¥175.249 million in the same period of the previous year to ¥183.799 million.
  21. FY2020Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥698.351 million.」

    Research and development expenses increased from ¥665.883 million in the previous fiscal year to ¥698.351 million.
  22. FY2020-Q3Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥516.791 million.」

    Research and development expenses increased from ¥487.107 million in the same period of the previous year to ¥516.791 million.
  23. FY2020-Q2Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥345.209 million.」

    Research and development expenses increased from ¥322.532 million in the same period of the previous year to ¥345.209 million.
  24. FY2020-Q1Increase in quarterly R&D expenseAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥175.249 million.」

    Research and development expenses increased from ¥165.083 million in the same period of the previous year to ¥175.249 million.
  25. FY2019Increase in investmentAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥665.883 million.」

    Research and development expenses increased from ¥635.721 million in the previous fiscal year to ¥665.883 million.
  26. FY2019-Q3RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥487.107 million.」

    Research and development expenses of ¥487.107 million were recorded for the cumulative third quarter, and research and development investment continued.
  27. FY2019-Q2RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥322.532 million.」

    Research and development expenses of ¥322.532 million were recorded for the cumulative second quarter, and research and development investment continued.
  28. FY2019-Q1RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥165.083 million.」

    Research and development expenses of ¥165.083 million were recorded for the first quarter, indicating continued investment in research and development.
  29. FY2018RestatedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥635.721 million.」

    The company continued its research and development investment and recorded annual research and development expenses of ¥635.721 million.
  30. FY2018-Q3RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥469.053 million.」

    The actual amount of research and development investment for the cumulative third quarter is stated.
  31. FY2018-Q2RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥314.615 million.」

    Research and development expenses for the cumulative second quarter are stated at the actual amount, indicating continued investment in research and development.
  32. FY2018-Q1RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥164.449 million.」

    Research and development expenses for the quarter are stated at the actual amount, indicating continued investment in research and development.
  33. FY2017-Q3RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative third quarter was ¥440.676 million.」

    Research and development expenses for the cumulative third quarter are stated at the actual amount.
  34. FY2017-Q2RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative second quarter was ¥291.118 million.」

    Research and development expenses for the cumulative second quarter are stated at the actual amount.
  35. FY2017-Q1RestatedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first quarter was ¥150.899 million.」

    Research and development expenses for the quarter are stated at the actual amount.
  36. FY2016First statedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥583.080 million.」

    The actual amount of research and development investment is stated.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Kaneko Seeds yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.